What Is Tcbp Stock? | All About Tcbp |

TC Biopharm (Holdings) Plc is a clinical-stage biopharmaceutical business engaged in the development of innovative immunotherapy medicines based on its proprietary allogeneic gamma delta T cell platform. The firm was founded in 2003 and is headquartered in the United Kingdom. The company was created in 2013 by Michael Leek and Angela Scott and has its headquarters in Motherwell, Scotland, United Kingdom of Great Britain and Northern Ireland.

Instructions on How to Purchase Tc Biopharm Holdings Stock

The American Depositary Shares of TC BioPharm (Holdings) plc are a biotechnology company based in the United States. The shares of TC BioPharm Holdings (TCBP) are traded on the NASDAQ, and all values are listed in US Dollars on the NASDAQ.

Tcbp Stock

TC BioPharm Holdings had 74 employees and generated revenue of around 0.00 in the preceding twelve months.

Compare and contrast different stock trading systems. Make use of our comparison table to help you pick a platform that best suits your needs and preferences.

Create an account with a brokerage firm. Fill out an application with all of your information.
Confirm the details of your payment. Make a deposit into your account.
Investigate the stock. TCBP – look for the stock by its ticker symbol or by its name and do some research to determine whether it is a good investment for you.

MUST READ- Power Finance Texas | Complete Information | Methods | Loans | Working |

You can make a purchase now or later. Purchase the number of shares you desire using a market order, or use a limit order to delay your purchase until the stock hits a particular price using a stop-limit order.
Keep an eye on the progress of your investment. Keeping track of your stocks might help you optimise your portfolio.

See also  Capital Investment Advisors: Objectives, Review, Services, Requirements

An Overview of Tc Biopharm Holdings

In addition to creating immunotherapy treatments based on its allogeneic gamma delta T cell platform, TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical firm, is focused on developing novel therapeutics for cancer.

Tcbp Stock

In addition to OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukaemia, ImmuniStim, an unmodified cell therapy used in the treatment of COVID-19, TCB009 for the treatment of gastrointestinal tract cancer,

READ ALSO – Sphere Finance |overview | Best Way to Purchase| Complete Information 2022 |

Are allogeneic co-stimulatory GD-T CAR pre-clinical drug candidates that would target antigens expressed on various solid tumour types, the company’s product pipeline includes The company was established in 2013 and has its headquarters in Motherwell, Scotland, in the United Kingdom?

Live Tcbp Quotes

NLS Volume 461
Previous Close $1.66
Today’s High / Low $1.60/$1.52
52 Week High / Low $3.5/$0.88

 

Leave a Reply

Your email address will not be published.